Alpharma Inc.’s Sale of Division to 3i

Cravath represented Alpharma Inc. in the sale of its Active Pharmaceutical Ingredients division to 3i for $395 million in cash. The lawyers involved in the matter were partner Robert I. Townsend, III and associates Anita M. Sra and Aaron Gruber on corporate matters; partner Stephen L. Gordon and associate Christian Brause on tax matters; and partner Eric W. Hilfers and associate Kerry Halpern-Skoglund on executive compensation & benefits matters. The deal was announced on February 6, 2008.